{"id":"https://openalex.org/W2080840740","doi":"https://doi.org/10.1097/00002371-200411000-00191","title":"Next Generation of Antibody-Directed Enzyme Prodrug Therapy","display_name":"Next Generation of Antibody-Directed Enzyme Prodrug Therapy","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W2080840740","doi":"https://doi.org/10.1097/00002371-200411000-00191","mag":"2080840740"},"language":"en","primary_location":{"id":"doi:10.1097/00002371-200411000-00191","doi":"https://doi.org/10.1097/00002371-200411000-00191","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-200411000-00191","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050940843","display_name":"Judith Ann Fox","orcid":"https://orcid.org/0000-0002-6084-7380","observed_orcids":["https://orcid.org/0000-0002-6084-7380"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith Fox","raw_affiliation_strings":["Preclinical Pharmacology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077821338","display_name":"Roanna Ueda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roanna Ueda","raw_affiliation_strings":["Preclinical Pharmacology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037275731","display_name":"Douglas Hodges","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas Hodges","raw_affiliation_strings":["Preclinical Pharmacology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018453715","display_name":"Peter Yeung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Yeung","raw_affiliation_strings":["Preclinical Pharmacology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087085239","display_name":"Daniel Brigham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Brigham","raw_affiliation_strings":["Preclinical Pharmacology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077111567","display_name":"Enrique Escand\u00f3n","orcid":"https://orcid.org/0000-0002-2297-969X","observed_orcids":["https://orcid.org/0000-0002-2297-969X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enrique Escandon","raw_affiliation_strings":["Preclinical Pharmacology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082082729","display_name":"Fiona Harding","orcid":"https://orcid.org/0000-0003-3817-1203","observed_orcids":["https://orcid.org/0000-0003-3817-1203"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fiona Harding","raw_affiliation_strings":["Cell Biology, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Biology, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015184600","display_name":"Lilia M. Bab\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lilia Babe","raw_affiliation_strings":["Protein Sciences, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Sciences, Genencor International, Palo Alto, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018783910","display_name":"Volker Schellenberger","orcid":"https://orcid.org/0000-0002-3491-8229","observed_orcids":["https://orcid.org/0000-0002-3491-8229"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Volker Schellenberger","raw_affiliation_strings":["Molecular Discovery, Genencor International, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery, Genencor International, Palo Alto, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20293791,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"6","first_page":"S53","last_page":"S53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adept","display_name":"ADEPT","score":0.972000002861023},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7839999794960022},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/enzyme-prodrug","display_name":"enzyme prodrug","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.8490194082260132},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5163482427597046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49920082092285156},{"id":"https://openalex.org/C2776904630","wikidata":"https://www.wikidata.org/wiki/Q356336","display_name":"Adept","level":3,"score":0.4865542948246002},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38353487849235535},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34846216440200806},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17972788214683533}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/00002371-200411000-00191","doi":"https://doi.org/10.1097/00002371-200411000-00191","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-200411000-00191","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2081058747","https://openalex.org/W1979694563","https://openalex.org/W1999530770","https://openalex.org/W4239026814","https://openalex.org/W2090560864","https://openalex.org/W2173729515","https://openalex.org/W2012977066","https://openalex.org/W2043396109","https://openalex.org/W2072343728","https://openalex.org/W1990763390"],"abstract_inverted_index":{"s":[0],"for":[1,11],"the":[2,8],"19th":[3],"Annual":[4],"Scientific":[5],"Meeting":[6],"of":[7,14],"International":[9],"Society":[10],"Biological":[12],"Therapy":[13],"Cancer,":[15],"San":[16],"Francisco,":[17],"California,":[18],"November":[19],"4-7,":[20],"2004:":[21],"New":[22],"Agents":[23],"in":[24],"Development":[25]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}